| Anesthesiologist Group 1 N = 939 | Resident Group 2 N = 2644 | CRNA/CAA Group 3 N = 11,501 | p-value |
---|---|---|---|---|
Age (years) | 51.8 ± 15.8 | 50.4 ± 15.9 | 50.7 ± 16.0 | 0.07 |
BMI (kg/m2) | 30.4 ± 7.4†| 29.5 ± 7.8 | 29.6 ± 7.5 | < 0.001 |
ASA score | 2 [2 - 3]†| 3 [2 - 3] | 3 [2 - 3] | < 0.001 |
GENDER (% male) | 41.0% | 45.2% | 45.1% | 0.91 |
Race (%) |  |  |  | < 0.001 |
American Indian/Alaska Native | 0.4% | 0.1% | 0.2% | Â |
Asian/Pacific Islander | 1.2% | 0.9% | 1.2% | Â |
Black | 29.2% | 37.9%* | 32.9% | Â |
Other/Unknown | 5.8% | 6.7% | 7.1% | Â |
White | 63.3% | 54.4%* | 58.7% | Â |
Anesthesia Base Units | 5.4 ± 1.8 | 5.3± 2.4 | 5.4 ± 2.3 | 0.74 |
Elixhauser Co-Morbidities a | Â | Â | Â | Â |
CAD (%) | 8.9% | 10.3% | 9.3% | 0.176 |
Cardiac Arrythmia (%) | 5.1%†| 13.7% | 12.2% | < 0.001 |
Chronic Pulmonary Disease (%) | 7.5%†| 13.7%* | 10.9% | < 0.001 |
Congestive Heart Failure (%) | 3.2%†| 5.5% | 4.6% | 0.009 |
HTN Complicated (%) | 5.8%†| 10.2% | 8.4% | < 0.001 |
HTN Uncomplicated (%) | 22.3%†| 30.1%* | 26.0% | < 0.001 |
Diabetes Complicated (%) | 2.7% | 4.4% | 3.8% | 0.18 |
Diabetes Uncomplicated (%) | 12.4% | 12.0% | 11.5% | 0.48 |
Peripheral Vascular Disease (%) | 2.0%†| 5.8%* | 4.1% | < 0.001 |
Renal Insufficiency (%) | 5.9% | 9.3%* | 7.7% | < 0.001 |